Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value

Biosci Rep. 2020 Oct 30;40(10):BSR20201431. doi: 10.1042/BSR20201431.

Abstract

Background: Increasing studies suggest that tumor immune infiltration is a relative factor of prognosis in ovarian cancer (OvCa). The present study explored the composition of tumor-infiltrating immune cells (TIICs) in OvCa using CIBERSORT algorithm and further assessed their values for prognosis and therapeutic strategies by molecular subtypes.

Methods: Publicly available databases including The Cancer Genome Atlas (TCGA) and GTEx were searched. Ovarian tumor samples were available from TCGA, and normal ovarian samples were obtained from the GTEx dataset. The relative proportions of immune cell profiling in OvCa and normal samples were evaluated by CIBERSORT algorithm. Association between each immune cell subtype and survival was inferred by the fractions of 22 immune cell types. "CancerSubtypes" R-package was employed to identify the three types of molecular classification and analyze the functional enrichment in each subclass. Response to immunotherapy and anticancer drug targets was predicted via TIDE algorithm and GDSC dataset.

Results: Substantial variation reflecting individual difference was identified between cancer and normal tissues in the immune infiltration profiles. T cells CD4 memory activated, macrophages M1 were associated with improved overall survival (OS) as evaluated by univariate Cox regression and multivariate Cox. Three subtypes were identified by ´CancerSubtypes' R-package and every sub-cluster possessed specific immune cell characterization. Meanwhile, Cluster II exhibited poor prognosis and sensitive response to immunotherapy.

Conclusions: The cellular component of immune infiltration shows remarkable variation in OvCa. Profiling of immune infiltration is useful in prediction of prognosis of OvCa. The results from profiling might be considered in therapeutic modulation.

Keywords: CIBERSORT algorithm; Immunotherapy; Ovarian cancer; Prognostic value; Tumor-infiltrating immune cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Immunological / pharmacology
  • Antineoplastic Agents, Immunological / therapeutic use
  • CD4-Positive T-Lymphocytes / immunology
  • Carcinoma, Ovarian Epithelial / drug therapy
  • Carcinoma, Ovarian Epithelial / immunology
  • Carcinoma, Ovarian Epithelial / mortality*
  • Carcinoma, Ovarian Epithelial / pathology
  • Datasets as Topic
  • Drug Resistance, Neoplasm / immunology
  • Feasibility Studies
  • Female
  • Humans
  • Immunologic Memory
  • Immunophenotyping*
  • Kaplan-Meier Estimate
  • Lymphocyte Activation
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Macrophages / immunology
  • Middle Aged
  • Neoplasm Invasiveness / immunology
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / mortality*
  • Ovarian Neoplasms / pathology
  • Ovary / cytology
  • Ovary / immunology*
  • Ovary / pathology
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment / methods
  • Survival Rate

Substances

  • Antineoplastic Agents, Immunological